{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T06:27:11Z","timestamp":1649053631380},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T00:00:00Z","timestamp":1299715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol Suppl"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s11789-011-0022-6","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T06:38:06Z","timestamp":1299652686000},"page":"58-65","source":"Crossref","is-referenced-by-count":0,"title":["Antikoagulation bei Vorhofflimmern"],"prefix":"10.1007","volume":"6","author":[{"given":"Hans","family":"Volkmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,10]]},"reference":[{"key":"22_CR1","doi-asserted-by":"crossref","unstructured":"Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohnloser SH, Kolh P, Le Heuzey J-Y, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation. The task force for the management of atrial fibrillation of the European society of cardiology. Eur Heart J. doi:10.1093\/eurheartj\/ehq278","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(06)68497-3","volume":"367","author":"S Connolly","year":"2006","unstructured":"Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Yusuf S (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of vascular events (ACTIVE W): a randomized controlled trial. Lancet 367:1139\u20131151","journal-title":"Lancet"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009a","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Temeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BJ, Darius H, Diener HC, Joyner CD, Wallentin L (2009a) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","volume":"360","author":"SJ Connolly","year":"2009b","unstructured":"Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S (2009b) Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 360:2066\u20132078","journal-title":"N Engl J Med"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/eurheartj\/ehl176","volume":"27","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S (2006) ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation \u2013 executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27:1979\u20132030","journal-title":"Eur Heart J"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.STR.32.3.803","volume":"32","author":"RG Hart","year":"2001","unstructured":"Hart RG, Halperin JL (2001) Atrial fibrillation and stroke: concepts and controversies. Stroke 32:803\u2013808","journal-title":"Stroke"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, McBride R et al (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492\u2013501","journal-title":"Ann Intern Med"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12181-010-0294-y","volume":"4","author":"HM Hoffmeister","year":"2010","unstructured":"Hoffmeister HM, Bode C, Darius H, Huber K, Rybak K, Silber S (2010) Unterbrechung antithrombotischer Behandlung (Bridging) bei kardialen Erkrankungen. Positionspapier. Kardiologe 4:365\u2013374","journal-title":"Kardiologe"},{"issue":"Suppl H","key":"22_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/eurheartj\/sun029","volume":"10","author":"SH Hohnloser","year":"2008","unstructured":"Hohnloser SH, Duray GZ, Baber U, Halperin JL (2008) Prevention of stroke in patients with atrial fibrillation: current strategies and future directions. Eur Heart J 10(Suppl H):4\u201310","journal-title":"Eur Heart J"},{"key":"22_CR10","doi-asserted-by":"crossref","unstructured":"Leith\u00e4user B, Kasch F, Broemel T, Park JW (2010) Persistierender linksatrialer Thrombus bei Vorhofflimmern unter oraler Antikagulation. Herz. doi:10.1007\/s00059-010-3384-5","DOI":"10.1007\/s00059-010-3384-5"},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12181-008-0080-2","volume":"2","author":"T Lewalter","year":"2008","unstructured":"Lewalter T, Tebbenjohanns J, Wichter T et al (2008) Kommentar zu \u201eACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation \u2013 executive summary\u201c. Kardiologe 2:181\u2013205","journal-title":"Kardiologe"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Huber K, Andreotti F, Arnesen H, Airaksinen JK, Cuisset T, Kirchhof P, Marin F (2010) Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing coronary stenting: executive summary \u2013 a Consensus Document of the European Society of Cardiology Working Group of Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 31:1311\u20131318","journal-title":"Eur Heart J"},{"key":"22_CR13","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Surves. Chest March 18"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ahj.2009.11.025","volume":"159","author":"ROCKET AF Study Investigators","year":"2010","unstructured":"ROCKET AF Study Investigators (2010) Rivaroxaban \u2013 once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation: rationale and design of the ROCKET AF study. Am Heart J 159:340\u2013347.e1","journal-title":"Am Heart J"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.amjcard.2008.08.021","volume":"102","author":"R Rossini","year":"2008","unstructured":"Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik l, Mantovani P, Sirbu V, Bass TA, Rovere FD, Gavazzi A, Angiolillo DJ (2008) Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol 102:1618\u20131623","journal-title":"Am J Cardiol"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","volume":"374","author":"R Sorensen","year":"2009","unstructured":"Sorensen R, Hansen ML, Abildstrom SZ et al (2009) Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet 374:1967\u20131974","journal-title":"Lancet"},{"key":"22_CR17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"The ACTIVE writing group on behalf of the ACTIVE investigators","year":"2006","unstructured":"The ACTIVE writing group on behalf of the ACTIVE investigators (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367:1903\u20131912","journal-title":"Lancet"},{"key":"22_CR18","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/eurheartj\/ehp194","volume":"30","author":"JM Tolsano","year":"2009","unstructured":"Tolsano JM et al (2009) Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. Eur Heart J 30:1880\u20131884","journal-title":"Eur Heart J"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/eurheartj\/ehm575","volume":"29","author":"AGG Turpie","year":"2008","unstructured":"Turpie AGG (2008) New oral anticoagulants in atrial fibrillation. Eur Heart J 29:155\u2013165","journal-title":"Eur Heart J"},{"issue":"Suppl 5","key":"22_CR20","first-page":"105","volume":"90","author":"S Vetter","year":"2001","unstructured":"Vetter S, Ullmann HM, Lauke G, Volkmann H (2001) Besonderheiten der Thromboembolieprophylaxe bei betagten Patienten mit Vorhofflimmern. Z Kardiol 90(Suppl 5):105","journal-title":"Z Kardiol"},{"key":"22_CR21","first-page":"7","volume":"34","author":"U Wiegand","year":"2010","unstructured":"Wiegand U (2010) Antikoagulationsmanagement bei Schrittmacher-\/ICD-Implantation. Med Report 34:7","journal-title":"Med Report"},{"key":"22_CR22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1378\/chest.126.4.1177","volume":"126","author":"UK Wiegand","year":"2004","unstructured":"Wiegand UK et al (2004) Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patients morbidity, operation strategy, and perioperative antiplatelet\/anticoagulation therapy. Chest 126:1177\u20131186","journal-title":"Chest"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott AD, Kannell WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22:983\u2013988","journal-title":"Stroke"}],"container-title":["Clinical Research in Cardiology Supplements"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-011-0022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11789-011-0022-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-011-0022-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T05:01:26Z","timestamp":1560056486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11789-011-0022-6"}},"subtitle":["Verhalten bei Problemsituationen"],"short-title":[],"issued":{"date-parts":[[2011,3,10]]},"references-count":23,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11789-011-0022-6","relation":{},"ISSN":["1861-0706","1861-0714"],"issn-type":[{"value":"1861-0706","type":"print"},{"value":"1861-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,10]]}}}